e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
N. Karoli, A. Rebrov (Russian Federation)
Source:
Annual Congress 2010 - Pulmonary circulation I
Session:
Pulmonary circulation I
Session type:
Thematic Poster Session
Number:
1104
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Karoli, A. Rebrov (Russian Federation). Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma. Eur Respir J 2010; 36: Suppl. 54, 1104
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Pulmonary hypertension in systemic scleroderma
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010
Arterial stiffness in systemic scleroderma patients with restrictive lung disease
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009
Systemic consequences of pulmonary arterial hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Pulmonary arterial manifestation of systemic inflammation in patients with COPD
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Pulmonary rehabilitation in patients with pulmonary arterial hypertension
Source: ERS Course 2017
Year: 2017
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018
Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Exercise pathophysiology in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Pulmonary arterial hypertension
Source: Breathe 2010; 6: 377-380
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept